HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CHPA Offers OTC Testing, Degradant Standards For Monograph Modernization

This article was originally published in The Tan Sheet

Executive Summary

The Consumer Healthcare Products Association looks to shape U.S. Pharmacopeia's revision of monographs for OTC drug ingredients and products with proposals for the standard-setting organization's monograph modernization process.

You may also be interested in...

USP Monograph Modernization Requires Flexibility For OTCs, Experts Agree

The U.S. Pharmacopeia monograph modernization initiative must take a flexible approach in order to accommodate formulation of complex OTC products, experts say.

Monograph Modernization Initiative Looks To Close OTC Quality Loopholes

A collaboration among industry, FDA and U.S. Pharmacopeia aims to address what FDA sees as a lack of insight into the quality and purity of OTC monograph drugs

FDA Seeks Public Input On Secrets Of Profit-Motivated Adulteration

FDA plans to hold a public workshop this spring to begin the task of combating profit-motivated adulteration of regulated products

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts